Статті в журналах з теми "Antifibrotic Agents"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Antifibrotic Agents".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Albanis, E., and S. L. Friedman. "Antifibrotic Agents for Liver Disease." American Journal of Transplantation 6, no. 1 (January 2006): 12–19. http://dx.doi.org/10.1111/j.1600-6143.2005.01143.x.
Повний текст джерелаLaCamera, Peter P., Susan L. Limb, Tmirah Haselkorn, Elizabeth A. Morgenthien, John L. Stauffer, and Mark L. Wencel. "Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis." Chronic Respiratory Disease 16 (January 1, 2019): 147997311987967. http://dx.doi.org/10.1177/1479973119879678.
Повний текст джерелаSkuta, Gregory L. "Antifibrotic Agents in Glaucoma Filtering Surgery." International Ophthalmology Clinics 33, no. 4 (1993): 165–82. http://dx.doi.org/10.1097/00004397-199303340-00014.
Повний текст джерелаOishi, Keiji, Tsunahiko Hirano, Yoriyuki Murata, Kazuki Hamada, Sho Uehara, Ryo Suetake, Yoshikazu Yamaji, et al. "Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study." Therapeutic Advances in Respiratory Disease 13 (January 2019): 175346661987289. http://dx.doi.org/10.1177/1753466619872890.
Повний текст джерелаKawada, Norifumi. "Antifibrotic agents emerging from traditional herbal medicine." Arab Journal of Gastroenterology 10, no. 4 (April 2010): S21—S22. http://dx.doi.org/10.1016/j.ajg.2009.12.007.
Повний текст джерелаGeismar, Lois S., Janet S. Kerr, Robert L. Trelstad, and David J. Riley. "Treatment of experimental silicosis with antifibrotic agents." Toxicology 53, no. 2-3 (December 1988): 331–44. http://dx.doi.org/10.1016/0300-483x(88)90225-9.
Повний текст джерелаGrotendorst, Gary R. "Identification and development of novel antifibrotic agents." Expert Opinion on Investigational Drugs 6, no. 6 (June 1997): 777–81. http://dx.doi.org/10.1517/13543784.6.6.777.
Повний текст джерелаJegal, Yangjin, Jong Sun Park, Song Yee Kim, Hongseok Yoo, Sung Hwan Jeong, Jin Woo Song, Jae Ha Lee, et al. "Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry." Tuberculosis and Respiratory Diseases 85, no. 2 (April 1, 2022): 185–94. http://dx.doi.org/10.4046/trd.2021.0123.
Повний текст джерелаSchuppan, Detlef, Muhammad Ashfaq-Khan, Ai Ting Yang, and Yong Ook Kim. "Liver fibrosis: Direct antifibrotic agents and targeted therapies." Matrix Biology 68-69 (August 2018): 435–51. http://dx.doi.org/10.1016/j.matbio.2018.04.006.
Повний текст джерелаPan, Xiaoqi, Xiao Ma, Yinxiao Jiang, Jianxia Wen, Lian Yang, Dayi Chen, Xiaoyu Cao, and Cheng Peng. "A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids." Evidence-Based Complementary and Alternative Medicine 2020 (October 5, 2020): 1–19. http://dx.doi.org/10.1155/2020/7171498.
Повний текст джерелаIsmail, Magda M. F., and Eman Noaman. "Novel Pirfenidone Analogs as Antifibrotic Agents: Synthesis and Antifibrotic Evaluation of 2-Pyridones and Fused Pyridones." Medicinal Chemistry Research 14, no. 7 (October 2005): 382–403. http://dx.doi.org/10.1007/s00044-006-0146-2.
Повний текст джерелаSlabaugh, Mark, and Sarwat Salim. "Use of Anti-VEGF Agents in Glaucoma Surgery." Journal of Ophthalmology 2017 (2017): 1–6. http://dx.doi.org/10.1155/2017/1645269.
Повний текст джерелаFitzgerald, L. J., D. N. O'Dwyer, E. Wakeam, D. M. Lyu, and M. P. Combs. "Evaluation of Pre-Transplant Antifibrotic Agents on Post-Transplant Outcomes." Journal of Heart and Lung Transplantation 41, no. 4 (April 2022): S422—S423. http://dx.doi.org/10.1016/j.healun.2022.01.1064.
Повний текст джерелаSelman, Moisés. "From Anti-inflammatory Drugs Through Antifibrotic Agents to Lung Transplantation." Chest 122, no. 3 (September 2002): 759–61. http://dx.doi.org/10.1378/chest.122.3.759.
Повний текст джерелаMannem, Hannah, and Alexander Sasha Krupnick. "Commentary: Antifibrotic agents in the postoperative period: Friends or foes?" Journal of Thoracic and Cardiovascular Surgery 158, no. 1 (July 2019): 297–98. http://dx.doi.org/10.1016/j.jtcvs.2019.02.102.
Повний текст джерелаTakehara, Kazutaka, Yasuhiko Koga, Yoshimasa Hachisu, Mitsuyoshi Utsugi, Yuri Sawada, Yasuyuki Saito, Seishi Yoshimi, et al. "Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis." Cells 11, no. 1 (January 2, 2022): 143. http://dx.doi.org/10.3390/cells11010143.
Повний текст джерелаHassanein, Tarek, Dean Tai, Chenghai Liu, Terry D. Box, Myron J. Tong, Lorenzo Rossaro, Renee Pozza, et al. "Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial." Evidence-Based Complementary and Alternative Medicine 2022 (July 15, 2022): 1–11. http://dx.doi.org/10.1155/2022/4494099.
Повний текст джерелаTanabe, Kiwamu, Tatsuya Usui, and Kazuaki Sasaki. "Search for novel antifibrotic agents using nonalcoholic steatohepatitis (NASH) organoid model." Proceedings for Annual Meeting of The Japanese Pharmacological Society 95 (2022): 1—LBS—04. http://dx.doi.org/10.1254/jpssuppl.95.0_1-lbs-04.
Повний текст джерелаRupcic Rubin, Vinka, Kristina Bojanic, Martina Smolic, Jurica Rubin, Ashraf Tabll, and Robert Smolic. "An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents." Journal of Clinical and Translational Hepatology 000, no. 000 (January 4, 2021): 1–11. http://dx.doi.org/10.14218/jcth.2020.00040.
Повний текст джерелаMa, Zhen, Youlu Pan, Wenhai Huang, Yewei Yang, Zunyuan Wang, Qin Li, Yin Zhao, Xinyue Zhang, and Zhengrong Shen. "Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents." Bioorganic & Medicinal Chemistry Letters 24, no. 1 (January 2014): 220–23. http://dx.doi.org/10.1016/j.bmcl.2013.11.038.
Повний текст джерелаTang, X., S. Teng, M. Petri, C. Krettek, C. Liu, and M. Jagodzinski. "The effect of anti-inflammatory and antifibrotic agents on fibroblasts obtained from arthrofibrotic tissue." Bone & Joint Research 7, no. 3 (March 2018): 213–22. http://dx.doi.org/10.1302/2046-3758.73.bjr-2017-0219.r2.
Повний текст джерелаLiang, Minrui, Eric L. Matteson, Andy Abril, and Jörg H. W. Distler. "The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease." Therapeutic Advances in Musculoskeletal Disease 14 (January 2022): 1759720X2210744. http://dx.doi.org/10.1177/1759720x221074457.
Повний текст джерелаCorrie, Leander, MD Muzaffar-Ur-Rehman, Latha Kukatil, Devasari Manasa, and Adepu Shirisha. "Antifibrotic Drugs for COVID-19: From Orphan Drugs to Blockbusters?" Current Respiratory Medicine Reviews 17, no. 1 (May 5, 2021): 8–12. http://dx.doi.org/10.2174/1573398x17666210304100043.
Повний текст джерелаKoga, Yasuhiko, Yoshimasa Hachisu, Hiroaki Tsurumaki, Masakiyo Yatomi, Kyoichi Kaira, Shoichiro Ohta, Junya Ono, Kenji Izuhara, Kunio Dobashi, and Takeshi Hisada. "Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels." Medicina 55, no. 5 (May 17, 2019): 161. http://dx.doi.org/10.3390/medicina55050161.
Повний текст джерелаGórska, Katarzyna, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem, et al. "Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland." Therapeutic Advances in Chronic Disease 13 (January 2022): 204062232211179. http://dx.doi.org/10.1177/20406223221117982.
Повний текст джерелаRoman, Jesse, and Hirofumi Chiba. "B Cells in Idiopathic Pulmonary Fibrosis: Targeting Immune Cells with Antifibrotic Agents." American Journal of Respiratory Cell and Molecular Biology 64, no. 6 (June 2021): 652–54. http://dx.doi.org/10.1165/rcmb.2021-0101ed.
Повний текст джерелаBudenz, Donald L., Mark Pyfer, Kuldev Singh, Jeffrey Gordon, Jody Piltz-Seymour, and Edwin U. Keates. "Comparison of Phacotrabeculectomy With 5-Fluorouracil, Mitomycin-C, and Without Antifibrotic Agents." Ophthalmic Surgery, Lasers and Imaging Retina 30, no. 5 (May 1999): 367–74. http://dx.doi.org/10.3928/1542-8877-19990501-08.
Повний текст джерелаAdtani, Pooja, Narasimhan Malathi, Kannan Ranganathan, Sivaswamy Lokeswari, and Alan Mathew Punnoose. "Antifibrotic effect of Ocimum basilicum L. and linalool on arecoline-induced fibrosis in human buccal fibroblasts." Translational Research in Oral Oncology 3 (January 1, 2018): 2057178X1876447. http://dx.doi.org/10.1177/2057178x18764471.
Повний текст джерелаLv, Wenshan, Fan Fan, Yangang Wang, Ezekiel Gonzalez-Fernandez, Chen Wang, Lili Yang, George W. Booz, and Richard J. Roman. "Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD." Physiological Genomics 50, no. 1 (January 1, 2018): 20–34. http://dx.doi.org/10.1152/physiolgenomics.00039.2017.
Повний текст джерелаSkurikhin, Evgenii, Vladimir Nebolsin, Darius Widera, Natalia Ermakova, Olga Pershina, Angelina Pakhomova, Vyacheslav Krupin, et al. "Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis." International Journal of Molecular Sciences 21, no. 21 (November 8, 2020): 8380. http://dx.doi.org/10.3390/ijms21218380.
Повний текст джерелаBurgess, Heather A., Louis Eugene Daugherty, Thomas H. Thatcher, Heather F. Lakatos, Denise M. Ray, Michelle Redonnet, Richard P. Phipps та Patricia J. Sime. "PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis". American Journal of Physiology-Lung Cellular and Molecular Physiology 288, № 6 (червень 2005): L1146—L1153. http://dx.doi.org/10.1152/ajplung.00383.2004.
Повний текст джерелаKumai, Yoshihiko. "Pathophysiology of Fibrosis in the Vocal Fold: Current Research, Future Treatment Strategies, and Obstacles to Restoring Vocal Fold Pliability." International Journal of Molecular Sciences 20, no. 10 (May 24, 2019): 2551. http://dx.doi.org/10.3390/ijms20102551.
Повний текст джерелаCollins, Bridget F., and Ganesh Raghu. "Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis." European Respiratory Review 28, no. 153 (September 30, 2019): 190022. http://dx.doi.org/10.1183/16000617.0022-2019.
Повний текст джерелаMorrow, Lee E., Daniel Hilleman, and Mark A. Malesker. "Management of patients with fibrosing interstitial lung diseases." American Journal of Health-System Pharmacy 79, no. 3 (October 5, 2021): 129–39. http://dx.doi.org/10.1093/ajhp/zxab375.
Повний текст джерелаZakaria, Sherin, та Alaa E. El-Sisi. "Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling Pathway". Current Molecular Pharmacology 13, № 4 (2 листопада 2020): 318–27. http://dx.doi.org/10.2174/1874467213666200116114919.
Повний текст джерелаYang, Cheng-Chun, Chin-Yu Chen, Yu-Ting Kuo, Ching-Chung Ko, Wen-Jui Wu, Chia-Hao Liang, Chun-Ho Yun, and Wei-Ming Huang. "Radiomics for the Prediction of Response to Antifibrotic Treatment in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study." Diagnostics 12, no. 4 (April 15, 2022): 1002. http://dx.doi.org/10.3390/diagnostics12041002.
Повний текст джерелаDuval, Florent, Jorge E. Moreno-Cuevas, Maria Teresa González-Garza, Carlos Rodríguez-Montalvo, and Delia Elva Cruz-Vega. "Liver Fibrosis and Protection Mechanisms Action of Medicinal Plants Targeting Apoptosis of Hepatocytes and Hepatic Stellate Cells." Advances in Pharmacological Sciences 2014 (2014): 1–11. http://dx.doi.org/10.1155/2014/373295.
Повний текст джерелаDuval, Florent, Jorge E. Moreno-Cuevas, María Teresa González-Garza, Carmen Maldonado-Bernal, and Delia Elva Cruz-Vega. "Liver Fibrosis and Mechanisms of the Protective Action of Medicinal Plants Targeting Inflammation and the Immune Response." International Journal of Inflammation 2015 (2015): 1–14. http://dx.doi.org/10.1155/2015/943497.
Повний текст джерелаKnobloch, K., A. Gohritz, M. Spies, and P. M. Vogt. "ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery." Interactive CardioVascular and Thoracic Surgery 7, no. 3 (March 26, 2008): 475–76. http://dx.doi.org/10.1510/icvts.2007.174698a.
Повний текст джерелаRaja, S. G. "ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery." Interactive CardioVascular and Thoracic Surgery 7, no. 3 (March 26, 2008): 476. http://dx.doi.org/10.1510/icvts.2007.174698a1.
Повний текст джерелаCassone, Giulia, Andreina Manfredi, Caterina Vacchi, Fabrizio Luppi, Francesca Coppi, Carlo Salvarani, and Marco Sebastiani. "Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows." Journal of Clinical Medicine 9, no. 4 (April 10, 2020): 1082. http://dx.doi.org/10.3390/jcm9041082.
Повний текст джерелаHewitson, Tim D. "Renal tubulointerstitial fibrosis: common but never simple." American Journal of Physiology-Renal Physiology 296, no. 6 (June 2009): F1239—F1244. http://dx.doi.org/10.1152/ajprenal.90521.2008.
Повний текст джерелаTuran, Onur, and Bünyamin Sertoğullarından. "Efficacy and tolerability of antifibrotic agents in idiopathic pulmonary fibrosis: An experience from Turkey." Eurasian Journal of Pulmonology 23, no. 1 (2021): 59. http://dx.doi.org/10.4103/ejop.ejop_74_20.
Повний текст джерелаSchnabl, Bernd, David Scholten, and David A. Brenner. "What is the potential role of antifibrotic agents for the treatment of liver disease?" Nature Clinical Practice Gastroenterology & Hepatology 5, no. 9 (July 15, 2008): 496–97. http://dx.doi.org/10.1038/ncpgasthep1200.
Повний текст джерелаLiu, Xiaoqiu, Rennolds S. Ostrom, and Paul A. Insel. "cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts." American Journal of Physiology-Cell Physiology 286, no. 5 (May 2004): C1089—C1099. http://dx.doi.org/10.1152/ajpcell.00461.2003.
Повний текст джерелаSOLOMON, ABRAHAM, URIEL TICHO, and JOSEPH FRUCHT-PERY. "Late-Onset, Bleb-Associated Endophthalmitis following Glaucoma Filtering Surgery with or without Antifibrotic Agents." Journal of Ocular Pharmacology and Therapeutics 15, no. 4 (August 1999): 283–93. http://dx.doi.org/10.1089/jop.1999.15.283.
Повний текст джерелаLee, Y. S., K. Y. Kim, B. S. Yu, K. S. Kil, J. Y. Jeong, J. J. Cho, and J. H. Che. "Development of hepatic fibrosis (cirrhosis) model in rats and screening of the antifibrotic agents." Toxicology Letters 95 (July 1998): 165. http://dx.doi.org/10.1016/s0378-4274(98)80660-7.
Повний текст джерелаLaw, Simon K. "A Modified Technique of Ahmed Glaucoma Valve Implantation with Adjunctive Use of Antifibrotic Agents." American Journal of Ophthalmology 146, no. 2 (August 2008): 156–58. http://dx.doi.org/10.1016/j.ajo.2008.05.003.
Повний текст джерелаBaxter, Ruth M., Thomas P. Crowell, Margaret E. McCrann, Erica M. Frew, and Humphrey Gardner. "Analysis of the tight skin (Tsk1/+) mouse as a model for testing antifibrotic agents." Laboratory Investigation 85, no. 10 (August 15, 2005): 1199–209. http://dx.doi.org/10.1038/labinvest.3700331.
Повний текст джерелаTaufiq, Ahmad, Rosy Eko Saputro, Hendra Susanto, Nurul Hidayat, Sunaryono Sunaryono, Tahta Amrillah, Husni Wahyu Wijaya, Nandang Mufti, and Firman Mangasa Simanjuntak. "Synthesis of Fe3O4/Ag nanohybrid ferrofluids and their applications as antimicrobial and antifibrotic agents." Heliyon 6, no. 12 (December 2020): e05813. http://dx.doi.org/10.1016/j.heliyon.2020.e05813.
Повний текст джерела